Previous studies have shown that the immunological profile of critically ill COVID‐19 patients demonstrated hyperactivation of the humoral immune pathway, including interleukin‐6 (IL‐6), which is a critical mediator for respiratory failure, shock, and multiorgan dysfunction.65, 66. This evidence concerns the gene IL6 and COVID-19.